Home › Trial NCT00004016
Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors
- Trial IDNCT00004016
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorUniversity of Rochester
- Enrollment—
- Start date1999-04
- ConditionsMelanoma (Skin) · Unspecified Adult Solid Tumor, Protocol Specific
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.